Dyadic Family Caregiver-person With Dementia Online InterventionLMH-4-DCPNCT06225986

Living Memory Home-4-Dementia Care Pairs

A study testing LMH-4-DCP and LMH-4-DCP access without reminiscence activities in people with Dyadic Family Caregiver-person With Dementia Online Intervention, run by Weill Medical College of Cornell University at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record

Search all trials

Trial summary

The purpose of this study is to evaluate an online platform -- the Living Memory Home for Dementia Care Pairs (LMH-4-DCP) for persons with dementia and their family caregivers to engage in reminiscence activities together and record meaningful memories. Read more about this study

Who is it for?: Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for: Dyadic Family Caregiver-person With Dementia Online Intervention
What is being tested?: LMH-4-DCP and LMH-4-DCP access without reminiscence activities
Type of treatment: Lifestyle or therapy programme
Could I receive a placebo?: No, everyone receives an active treatment
How many people: 74 participants
Where: 1 siteUnited States
Study dates: 6 Nov 2024to 20 Aug 2025
Phase: Interventional
Are there results?: Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

Ages 18 years and older
All sexes
Healthy volunteers accepted
Adult, Older adult

Who may be able to join

Family Caregivers:
be a primary source of care for a family member in the early to moderate stages of dementia
18 years of age or older
English-speaking
able to use the internet and has internet access
residing in the United States

Who cannot join

Caregiver exclusion criteria:
is not the primary family caregiver of the PwD
under the age of 18-years-old
exhibits cognitive impairment (by scoring 3 or more on the SPMSQ)
does not speak English as a primary language.
PwD exclusion criteria:

Show all 11Show fewer

severe cognitive impairment detected by the clinical or study staff using validated, brief screening tools (e.g., a score of 8 errors or more on the SPMSQ)
does not demonstrate capacity to consent (e.g., a score of 9 or fewer errors on the University of California-San Diego Brief Assessment of Capacity to consent
PwD is living in a long-term care facility
does not speak English as a primary language
is under the age of 18 years old.

Trial locations and contacts

1 site in 1 country.

United States1 site

Weill Cornell Medicine
New York, New York, 10021

Other trials in United States

About this study

Official title: The Living Memory Home: Reducing Grief and Improving Relationships Between Home-Based Patients With ADRD and Their Family Caregivers

The main aims of this study are:

To evaluate the feasibility and acceptability of the LMH-4-DCP platform.
To explore the potential for LMH-4-DCP to reduce feelings of pre-loss grief and enhancing relationship quality in dementia family caregivers and their care-recipients ('Care-Pairs')

Care pair participants will be asked to log-in to LMH-4-DCP and complete study activities three times per week for two weeks. Researchers will compare the intervention group to an attention control condition to see if LMH-4-DCP's use is associated with reduced feelings of caregiver pre-loss grief and improved care pair relationship quality at follow-up.

Read the detailed description

The goal of this randomized controlled trial is to evaluate the Living Memory Home for Dementia Care Pairs (LMH-4-DCP) web application, a dyadic online psychosocial reminiscence platform, to reduce feelings of pre-loss grief and improve relationship quality in individuals with dementia and their family caregivers ('Care Pairs').

The main aims of this study are:

To evaluate the feasibility and acceptability of the LMH-4-DCP platform.
To explore the influence of the LMH-4-DCP intervention on reducing feelings of pre-loss grief and enhancing relationship quality in the care pair

Caregiver participants randomized to the intervention condition will be asked to log-in to LMH-4-DCP and complete reminiscence activities three times per week for two weeks. Researchers will compare the intervention group to an attention control condition, which includes LMH-4-DCP use without reminiscence-specific features, to see if LMH-4-DCP's use is associated with reduced feelings of caregiver pre-loss grief and improved care pair relationship quality at follow-up.

Conditions: Dyadic Family Caregiver-person With Dementia Online Intervention
Being tested: LMH-4-DCP, LMH-4-DCP access without reminiscence activities

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

LMH-4-DCPBehavioural
Reminiscence-based intervention for family caregiver-Persons with Dementia (PwD) dyads to record and reflect on meaningful memories to address family caregivers' pre-loss grief and enhance relationship quality.
LMH-4-DCP access without reminiscence activitiesBehavioural
Participants in the attention control condition will have access to a version of LMH-4-DCP excluding reminiscence-specific activities.

Study groups in NCT06225986
Study group	Role	What they receive
LMH-4-DCP Intervention	Experimental	Not described Receives: Behavioral: LMH-4-DCP
Attention Control Arm	Active comparator	Not described Receives: Behavioral: LMH-4-DCP access without reminiscence activities

What is being measured

The primary outcome is the main question the study is designed to answer.

The Feasibility of the LMH-4-DCP Application as Measured by the Number of Website Logins Per Participant Out of Total Required (Minimum = 6).
The feasibility of the application will be measured by the number of times the participant logs in to the LMH-4-DCP web application. The minimum number of logins recommended to the participants is 6.
Measured: 2 Weeks
The Feasibility of the LMH-4-DCP Study as Measured by Participant Retention, as Indicated by the Number of Participants Lost to Follow-Up.
Participant retention, as an aspect of feasibility, will be measured by the recorded number of participants lost to follow-up. A number of the enrolled participants who the study team contacted three times, but did not answer or continue participation, will be recorded.
Measured: 2 Weeks
The Feasibility of the LMH-4-DCP Study as Measured by Participant Retention, as Indicated by the Number of Recorded Dropouts.
Participant retention, as an aspect of feasibility, will be measured by the recorded number of dropouts. A number of the participants who asked to withdraw/drop-out from the study after being enrolled will be recorded.
Measured: 2 Weeks
The Feasibility of the LMH-4-DCP Application as Measured by the Time Spent in Each Activity Within the Web Application.
The feasibility of the application will be measured by the time spent in each activity. The time will be measured in minutes and seconds. For example, 5 minutes and 30 seconds.
Measured: 2 Weeks
The Feasibility of the LMH-4-DCP Study as Measured by Recruitment Rates and the Proportion of Family Caregivers Who (1) Consent to Participate.
The feasibility of the LMH-4-DCP study will be measured by the proportion of family caregivers who consent to participate among those who were invited and screened into the study.
Measured: 2 Weeks
The Feasibility of the LMH-4-DCP Study as Measured by Recruitment Rates and the Proportion of Family Caregivers (2) Decline Participation.
The feasibility of the LMH-4-DCP study will be measured by the proportion of family caregivers who decline to participate among those who were invited and screened into the study.
Measured: 2 Weeks
The Feasibility of the LMH-4-DCP Study as Measured by Recruitment Rates and the Proportion of (3) Are Deemed Ineligible Based on Screening Criteria.
The feasibility of the LMH-4-DCP study will be measured by the proportion of family caregivers who are deemed ineligible based on screening criteria among those who were invited to participate in the study.
Measured: 2 Weeks
The Usability of the LMH-4-DCP Application as Measured by the System Usability Scale (SUS).
The usability of the web application will be measured by the System Usability Scale (SUS). This scale is a 10-item assessment of the usability of a system, helping identify areas for improvement. Response options range from 1 - Strongly Disagree to 5 - Strongly Agree. Scores range from 0-100, with higher scores indicative of greater usability.
Measured: 2 Weeks
The Acceptability of the LMH-4-DCP Application as Measured by a Survey That Measures the Participants Satisfaction and Acceptability of the Application.
The acceptability of the LMH-4-DCP application was assessed among caregiver participants assigned to the intervention arm using a study-specific survey evaluating usability, engagement, acceptability, and suggestions for improvement. Participants rated their agreement with statements such as "I enjoyed my experience using the LMH-4-DCP application" on a five-point Likert scale ranging from 1 - Strongly Disagree to 5 - Strongly Agree. Total scores range from 8 to 40, with higher scores indicating greater satisfaction and acceptability of the intervention.
Measured: 2 Weeks
The Acceptability of the LMH-4-DCP Application as Measured by a Qualitative Survey That Measures the Participants Satisfaction and Acceptability of the Application.
The acceptability of the web application will be measured by the use of open-ended items assessing usability, engagement, acceptability, suggestions for improvement. The intervention group participants will also be administered five open-ended qualitative items asking for feedback on LMH-4-DCP, including: "How was your overall experience using LMH-4-DCP?" and "Which LMH-4-DCP features did you find most valuable? Why?"
Measured: 2 Weeks

Secondary outcomes (4)

Change in Grief Severity as Measured by the Pre-Loss Prolonged Grief Revised (PG-12-R) Instrument.
The caregivers' pre-loss grief is assessed using the validated 12-Item Prolonged Grief Revised (PG-12-R) Measure. Scores range from 12-60, with higher scores indicative of greater feelings of pre-loss grief.
Measured: Baseline, 2 Weeks
Change in Relationship Quality as Measured by the Relational Deprivation Scale.
The first measure of relationship quality will be the validated 6-item Relational Deprivation Scale, which measures the perceived loss of relationship as a result of the care-recipient's illness. Response options range from 1 - Not At All to 4 - Completely. Scores range from 6-24, with higher scores indicative of poorer relational quality.
Measured: Baseline, 2 Weeks
Change in Relationship Quality as Measured by the Mutuality Scale.
The second measure of relationship quality will be the validated 15-item Mutuality Scale, which measures the extent of positive aspects of caregiving. Response options range from 0 - Not At All to 4 - A Great Deal. Scores range from 0-60, with higher scores reflecting greater levels of mutuality.
Measured: Baseline, 2 Weeks
Change in Relationship Quality as Measured by the Relationship Rewards Scale.
The third measure of relationship quality will be the 8-item validated Relationship Rewards Scale (RRS) instrument, which includes two subscales assessing caregivers' perceptions of relationship quality prior to the care-recipient's diagnosis ("pre-illness") and at the current time ("current relationship"). Responses range from 1 - Never to 4 - Always. Scores for each subscale range from 4-16, with higher scores indicating greater perceived relationship quality.
Measured: Baseline, 2 Weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

6 Nov 202420 Aug 2025

First posted26 Jan 2024
Study start6 Nov 2024
Primary completion20 Aug 2025
Study completion20 Aug 2025

Resources

Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
Posted resultsParticipant flow, outcome measures and adverse events reported by the sponsor.
Publications (2)Papers the sponsor has linked to this study.
Other trials for Dyadic Family Caregiver-person With Dementia Online InterventionStudies of the same condition, open and under way.
More trials run by Weill Medical College of Cornell UniversityThe sponsor's other registered studies.
What the trial phases meanHow a treatment moves from first tests in people to approval.

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design

Study type: Interventional
Phase: Phase N/A
Primary purpose: Supportive care
Allocation: Randomised
Intervention model: Parallel groups
Masking: Single blind
Who is masked: Participant
Enrolment: 74 participants (actual)

IDs, dates and publications

ClinicalTrials.gov ID: NCT06225986
Sponsor's protocol ID: 23-07026251
Other IDs: R21AG077144
Acronym: LMH-4-DCP
Status last verified: Jun 2026
First submitted: 9 Jan 2024
Last updated: 22 Jul 2026
Results posted: Yes, on ClinicalTrials.gov
Data monitoring committee: No
FDA-regulated drug: No
FDA-regulated device: No
Individual data sharing: Yes: Data collected for the LMH-4-Dementia Care Pairs study will only be shared after we have published the data addressing the study's specific aims. Intellectual property and data generated under this project will be administered in accordance with both Weill Cornell Medicine (WCM) and NIH policies, including the NIH Data Sharing Policy and Implementation Guidance. After publication of our main findings, access to databases and associated software tools generated and the code to create these tools under the project will be available for educational, research and non-profit purposes.

Publications

Falzarano FB, Greenfield A, Saviano SC, Kolla S, Korian S, Osso F, Miller J, Whitson HE, Maciejewski PK, Prigerson HG. Digital Reminiscence for Predeath Grief Among Family Caregivers of Patients With Dementia: A Pilot Randomized Clinical Trial. JAMA Netw Open. 2026 Apr 1;9(4):e268278. doi: 10.1001/jamanetworkopen.2026.8278.
PubMed 42018322
Falzarano FB, Greenfield A, Saviano SC, Kolla S, Korian S, Osso F, Miller J, Maciejewski PK, Whitson HE, Prigerson HG. Living Memory Home for Dementia Care Pairs (LMH-4-DCP): study protocol for a pilot randomized trial of a web-based reminiscence intervention for family caregivers and persons with dementia. Pilot Feasibility Stud. 2026 Apr 14;12(1):79. doi: 10.1186/s40814-026-01781-2.
PubMed 41975550

Study at a glance

From the registry record, last updated by the sponsor on 22 Jul 2026. Recruitment status is as the sponsor reported it: confirm with the study team.

Official title: The Living Memory Home: Reducing Grief and Improving Relationships Between Home-Based Patients With ADRD and Their Family Caregivers
ClinicalTrials.gov ID: NCT06225986
Acronym / sponsor ID: LMH-4-DCP / 23-07026251
Conditions: Dyadic Family Caregiver-person With Dementia Online Intervention
Study type: Interventional
Recruitment status: Completed
Enrolment: 74 participants (actual)
Lead sponsor: Weill Medical College of Cornell UniversityUniversity, hospital or other
Collaborators: National Institute on Aging (NIA)
Study start: 6 Nov 2024 (actual)
Primary completion: 20 Aug 2025 (actual)
Study completion: 20 Aug 2025 (actual)
First posted: 26 Jan 2024 (actual)
Results: Posted 22 Jul 2026

Clinical summary

The research question as the sponsor registered it. This describes what the study plans to test, not what it found.

The main aims of this study are:

To evaluate the feasibility and acceptability of the LMH-4-DCP platform.
To explore the potential for LMH-4-DCP to reduce feelings of pre-loss grief and enhancing relationship quality in dementia family caregivers and their care-recipients ('Care-Pairs')

Detailed description

The main aims of this study are:

To evaluate the feasibility and acceptability of the LMH-4-DCP platform.
To explore the influence of the LMH-4-DCP intervention on reducing feelings of pre-loss grief and enhancing relationship quality in the care pair

Study design

Primary purpose: Supportive care
Allocation: Randomised
Intervention model: Parallel groups
Masking: Single blind (participant)
Number of arms: 2

Arm	Type	Receives
LMH-4-DCP Intervention	Experimental	Behavioral: LMH-4-DCP
Attention Control Arm	Active comparator	Behavioral: LMH-4-DCP access without reminiscence activities

Who may qualify

Ages: 18 years and older
Sex: All
Healthy volunteers: Accepted
Age groups: Adult, Older adult

Key inclusion criteria (6 listed)

be a primary source of care for a family member in the early to moderate stages of dementia
18 years of age or older
English-speaking
able to use the internet and has internet access
residing in the United States

Key exclusion criteria (11 listed)

is not the primary family caregiver of the PwD
under the age of 18-years-old
exhibits cognitive impairment (by scoring 3 or more on the SPMSQ)
does not speak English as a primary language.
severe cognitive impairment detected by the clinical or study staff using validated, brief screening tools (e.g., a score of 8 errors or more on the SPMSQ)

Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.

Interventions

Intervention	Type	Arms
LMH-4-DCPReminiscence-based intervention for family caregiver-Persons with Dementia (PwD) dyads to record and reflect on meaningful memories to address family caregivers' pre-loss grief and enhance relationship quality.	Behavioural	LMH-4-DCP Intervention
LMH-4-DCP access without reminiscence activitiesParticipants in the attention control condition will have access to a version of LMH-4-DCP excluding reminiscence-specific activities.	Behavioural	Attention Control Arm

Primary outcome

The Feasibility of the LMH-4-DCP Application as Measured by the Number of Website Logins Per Participant Out of Total Required (Minimum = 6).
Time frame: 2 Weeks
The feasibility of the application will be measured by the number of times the participant logs in to the LMH-4-DCP web application. The minimum number of logins recommended to the participants is 6.
The Feasibility of the LMH-4-DCP Study as Measured by Participant Retention, as Indicated by the Number of Participants Lost to Follow-Up.
Time frame: 2 Weeks
Participant retention, as an aspect of feasibility, will be measured by the recorded number of participants lost to follow-up. A number of the enrolled participants who the study team contacted three times, but did not answer or continue participation, will be recorded.
The Feasibility of the LMH-4-DCP Study as Measured by Participant Retention, as Indicated by the Number of Recorded Dropouts.
Time frame: 2 Weeks
Participant retention, as an aspect of feasibility, will be measured by the recorded number of dropouts. A number of the participants who asked to withdraw/drop-out from the study after being enrolled will be recorded.
The Feasibility of the LMH-4-DCP Application as Measured by the Time Spent in Each Activity Within the Web Application.
Time frame: 2 Weeks
The feasibility of the application will be measured by the time spent in each activity. The time will be measured in minutes and seconds. For example, 5 minutes and 30 seconds.
The Feasibility of the LMH-4-DCP Study as Measured by Recruitment Rates and the Proportion of Family Caregivers Who (1) Consent to Participate.
Time frame: 2 Weeks
The feasibility of the LMH-4-DCP study will be measured by the proportion of family caregivers who consent to participate among those who were invited and screened into the study.
The Feasibility of the LMH-4-DCP Study as Measured by Recruitment Rates and the Proportion of Family Caregivers (2) Decline Participation.
Time frame: 2 Weeks
The feasibility of the LMH-4-DCP study will be measured by the proportion of family caregivers who decline to participate among those who were invited and screened into the study.
The Feasibility of the LMH-4-DCP Study as Measured by Recruitment Rates and the Proportion of (3) Are Deemed Ineligible Based on Screening Criteria.
Time frame: 2 Weeks
The feasibility of the LMH-4-DCP study will be measured by the proportion of family caregivers who are deemed ineligible based on screening criteria among those who were invited to participate in the study.
The Usability of the LMH-4-DCP Application as Measured by the System Usability Scale (SUS).
Time frame: 2 Weeks
The usability of the web application will be measured by the System Usability Scale (SUS). This scale is a 10-item assessment of the usability of a system, helping identify areas for improvement. Response options range from 1 - Strongly Disagree to 5 - Strongly Agree. Scores range from 0-100, with higher scores indicative of greater usability.
The Acceptability of the LMH-4-DCP Application as Measured by a Survey That Measures the Participants Satisfaction and Acceptability of the Application.
Time frame: 2 Weeks
The acceptability of the LMH-4-DCP application was assessed among caregiver participants assigned to the intervention arm using a study-specific survey evaluating usability, engagement, acceptability, and suggestions for improvement. Participants rated their agreement with statements such as "I enjoyed my experience using the LMH-4-DCP application" on a five-point Likert scale ranging from 1 - Strongly Disagree to 5 - Strongly Agree. Total scores range from 8 to 40, with higher scores indicating greater satisfaction and acceptability of the intervention.
The Acceptability of the LMH-4-DCP Application as Measured by a Qualitative Survey That Measures the Participants Satisfaction and Acceptability of the Application.
Time frame: 2 Weeks
The acceptability of the web application will be measured by the use of open-ended items assessing usability, engagement, acceptability, suggestions for improvement. The intervention group participants will also be administered five open-ended qualitative items asking for feedback on LMH-4-DCP, including: "How was your overall experience using LMH-4-DCP?" and "Which LMH-4-DCP features did you find most valuable? Why?"

4 secondary outcomes

Change in Grief Severity as Measured by the Pre-Loss Prolonged Grief Revised (PG-12-R) Instrument.
Time frame: Baseline, 2 Weeks
Change in Relationship Quality as Measured by the Relational Deprivation Scale.
Time frame: Baseline, 2 Weeks
Change in Relationship Quality as Measured by the Mutuality Scale.
Time frame: Baseline, 2 Weeks
Change in Relationship Quality as Measured by the Relationship Rewards Scale.
Time frame: Baseline, 2 Weeks

Results and safety

Results posted to the registry on 22 Jul 2026, as reported by the sponsor. Figures are copied from the record, not re-analysed. Full results on ClinicalTrials.gov.

Participant flow

Group	Started	Completed
LMH-4-DCP Intervention	34	27
Attention Control Arm	34	27

Primary outcome: The Feasibility of the LMH-4-DCP Application as Measured by the Number of Website Logins Per Participant Out of Total Required (Minimum = 6).

Time frame: 2 Weeks. Mean (Standard Deviation). Unit: Platform Logins

Measure	LMH-4-DCP Intervention n = 34	Attention Control Arm n = 34
Value	4.57 (3.75)	4.87 (3.79)

LMH-4-DCP Intervention vs Attention Control Arm: p = 0.74, t-test, 2 sided

Population analysed: This outcome measure was assessed among enrolled caregiver participants only.

Primary outcome: The Feasibility of the LMH-4-DCP Study as Measured by Participant Retention, as Indicated by the Number of Participants Lost to Follow-Up.

Time frame: 2 Weeks. Count of participants. Unit: Participants

Measure	LMH-4-DCP Intervention n = 34	Attention Control Arm n = 34
Value	6	5

LMH-4-DCP Intervention vs Attention Control Arm: p = 0.74, Fisher Exact

Population analysed: This outcome measure was assessed among enrolled caregiver participants only.

Primary outcome: The Feasibility of the LMH-4-DCP Study as Measured by Participant Retention, as Indicated by the Number of Recorded Dropouts.

Time frame: 2 Weeks. Count of participants. Unit: Participants

Measure	LMH-4-DCP Intervention n = 34	Attention Control Arm n = 34
Value	1	1

LMH-4-DCP Intervention vs Attention Control Arm: p = 0.99, Fisher Exact

Population analysed: This outcome measure was assessed among enrolled caregiver participants only.

Primary outcome: The Feasibility of the LMH-4-DCP Application as Measured by the Time Spent in Each Activity Within the Web Application.

Time frame: 2 Weeks. Mean (Standard Deviation). Unit: minutes

Population analysed: Data were not collected because the developer was ultimately unable to capture duration data. Time spent within each LMH-4-DCP activity was intended to be captured through web application analytics; however, the functionality required to record activity duration data was not successfully implemented during platform development. As a result, duration data were not collected for participants in either study arm, and no analyses could be conducted for this outcome measure.

4 secondary outcomes are reported in the full results.

Adverse events

Time frame: 6 Weeks. Other adverse events reported at 0% frequency or more

Group	Serious adverse events	Other adverse events	Deaths
LMH-4-DCP Intervention	0 of 34 (0%)	0 of 34 (0%)	0 of 34
Attention Control Arm	0 of 34 (0%)	0 of 34 (0%)	0 of 34

Limitations and caveats (from the sponsor): The LMH-4-DCP application was unable to capture time spent in each activity. Additionally, due to a technical issue in survey administration, changes in relationship quality (mutuality) could not be measured. As a result, data for both a primary and secondary outcome were either missing or uninterpretable.

Loading the posted results from ClinicalTrials.gov…

Research links

Official record on ClinicalTrials.govLast updated by the sponsor 22 Jul 2026.
Posted resultsParticipant flow, baseline, all outcome measures and adverse events.
Derived from this study: PubMed 42018322Falzarano FB, Greenfield A, Saviano SC, Kolla S, Korian S, Osso F, Miller J, Whitson HE, Maciejewski PK, Prigerson HG. Digital Reminiscence for Predeath Grief Among Family Caregivers of Patients With Dementia: A Pilot Randomized Clinical Trial. JAMA Netw Open. 2026 Apr 1;9(4):e268278. doi: 10.1001/jamanetworkopen.2026.8278.
Derived from this study: PubMed 41975550Falzarano FB, Greenfield A, Saviano SC, Kolla S, Korian S, Osso F, Miller J, Maciejewski PK, Whitson HE, Prigerson HG. Living Memory Home for Dementia Care Pairs (LMH-4-DCP): study protocol for a pilot randomized trial of a web-based reminiscence intervention for family caregivers and persons with dementia. Pilot Feasibility Stud. 2026 Apr 14;12(1):79. doi: 10.1186/s40814-026-01781-2.
Individual participant dataSharing planned: Yes. Data collected for the LMH-4-Dementia Care Pairs study will only be shared after we have published the data addressing the study's specific aims. Intellectual property and data generated under this project will be administered in accordance with both Weill Cornell Medicine (WCM) and NIH policies, including the NIH Data Sharing Policy and Implementation Guidance. After publication of our main findings, access to databases and associated software tools generated and the code to create these tools under the project will be available for educational, research and non-profit purposes.

Referral and contact

AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.

Holly Prigerson, PhD principal investigator

Weill Medical College of Cornell University

Francesca Falzarano, PhD principal investigator

University of Southern California; Weill Cornell Medicine

1 site in 1 country: see every site and its status.

Questions about this trial

What is this clinical trial studying?

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 22 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 22 Jul 2026). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The Feasibility of the LMH-4-DCP Application as Measured by the Number of Website Logins Per Participant Out of Total Required (Minimum = 6). (time frame: 2 Weeks). The study lists 10 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06225986, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Jul 2026.